Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...